tiprankstipranks
Trending News
More News >
Veeva Systems (VEEV)
NYSE:VEEV
Advertisement

Veeva Systems (VEEV) AI Stock Analysis

Compare
4,632 Followers

Top Page

VEEV

Veeva Systems

(NYSE:VEEV)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 4o)
Rating:66Neutral
Price Target:
$264.00
▲(9.39% Upside)
Veeva Systems' strong financial performance and strategic initiatives in AI and Crossix are significant positives. However, bearish technical indicators and a high P/E ratio suggest caution. The balanced sentiment from the earnings call reflects both opportunities and challenges, resulting in a moderate overall stock score.
Positive Factors
Revenue Growth
Exceeding revenue expectations indicates strong demand and effective execution, supporting long-term growth and market leadership.
AI Innovation
Veeva's focus on AI innovation enhances its product offerings, potentially increasing efficiency and customer satisfaction, driving future growth.
Strong Cash Flow
Robust cash flow conversion supports operational flexibility and strategic investments, ensuring long-term financial health and stability.
Negative Factors
CRM Customer Migration Risks
Potential loss of CRM customers to competitors could impact revenue, challenging Veeva's market position in this segment.
Moderating Revenue Growth
Slower revenue growth could indicate market saturation or increased competition, potentially affecting future earnings and expansion.
Loss of EDC Customer
Losing a key customer to a competitor may signal competitive pressures in the EDC market, impacting Veeva's growth prospects.

Veeva Systems (VEEV) vs. SPDR S&P 500 ETF (SPY)

Veeva Systems Business Overview & Revenue Model

Company DescriptionVeeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
How the Company Makes MoneyVeeva Systems generates revenue primarily through a subscription-based model, where clients pay for access to its cloud-based software solutions. The company offers various pricing tiers based on the specific services and features utilized by its customers. Key revenue streams include subscriptions for its core products like Veeva Vault and Veeva CRM, as well as additional services such as consulting and support. Veeva also derives income from multi-year contracts with clients, which provide predictable long-term revenue. Significant partnerships with major pharmaceutical companies and strategic alliances in the life sciences ecosystem further enhance its market position and contribute to sustained earnings growth, as these collaborations often lead to increased adoption of Veeva's platform and services.

Veeva Systems Key Performance Indicators (KPIs)

Any
Any
Revenue by Segment
Revenue by Segment
Shows revenue distribution across various business segments, indicating which segments drive growth and how diversified Veeva Systems' income streams are.
Chart InsightsVeeva Systems' Subscription Services segment has shown consistent growth, bolstered by strong performance in Vault CRM and Crossix, which saw over 30% year-over-year growth. Despite macroeconomic uncertainties, Veeva's strategic focus on AI and expansion into horizontal CRM markets is driving optimism. The Professional Services segment, however, shows fluctuating growth, possibly impacted by macro pressures. The company's robust execution and achievement of a $3 billion revenue run rate goal underscore its resilience and strategic agility in navigating market challenges.
Data provided by:The Fly

Veeva Systems Earnings Call Summary

Earnings Call Date:Nov 20, 2025
(Q3-2026)
|
% Change Since: |
Next Earnings Date:Mar 04, 2026
Earnings Call Sentiment Neutral
The earnings call presented a balanced view of Veeva Systems Inc.'s performance, with strong revenue growth and innovation in AI and Crossix, but challenges in customer retention in the CRM segment and potential revenue risks from customer migrations.
Q3-2026 Updates
Positive Updates
Strong Q3 Performance
Veeva Systems Inc. reported total revenue of $811 million and non-GAAP operating income of $365 million, exceeding guidance.
Veeva AI Initiative Progress
Veeva AI is making excellent progress, with significant innovation across product areas like Vault CRM, Crossix, clinical, and safety.
Crossix Growth
Crossix continues to perform well, with strong growth in both measurement and audiences segments, indicating a long runway for continued growth.
Increase in Commercial Subscription Revenues
Commercial subscription revenues have been raised by about $60 million year to date, indicating strong performance in this segment.
Expansion in Quality Cloud
The Quality Cloud opportunity is expanding, driven by new products like batch release and computer systems validation.
Negative Updates
CRM Customer Migration Risks
14 out of the top 20 customers are expected to migrate to Vault CRM, but six are potentially opting for other solutions, posing a risk to CRM revenue.
Loss of a Top 20 EDC Customer
A competitor has won back a top 20 customer on the EDC side, although Veeva believes this is not indicative of a broader trend.
Challenges in the CRM Market
The CRM suite, which is about 20% of total revenue, faces challenges as some top 20 customers opt for custom solutions or competitors.
Company Guidance
During the Veeva Systems Inc. fiscal 2026 third quarter earnings call, the company reported robust performance with total revenue of $811 million and a non-GAAP operating income of $365 million, exceeding prior guidance. Veeva AI was highlighted as a major initiative, with significant progress made across its product lines, including Vault CRM, Crossix, clinical, and safety. The CRM segment, which now constitutes about 20% of total revenue, saw 14 out of 20 top customers expected to migrate to Vault CRM, with discussions ongoing about potential revenue risks and opportunities for win-backs. The call also emphasized the strong performance of Crossix and the growing importance of digital marketing, with expectations for continued growth in that area. Additionally, the company discussed the strategic value of its business consulting and data services, as well as the long-term potential of its Veeva AI offerings, particularly in enhancing operational efficiencies and insight generation.

Veeva Systems Financial Statement Overview

Summary
Veeva Systems exhibits strong financial performance with consistent revenue growth, high profitability margins, and a robust balance sheet. The company maintains low leverage and generates substantial cash flows, supporting its operational and strategic initiatives. While revenue and free cash flow growth have moderated, the company's financial stability and efficiency remain commendable.
Income Statement
85
Very Positive
Veeva Systems demonstrates strong financial performance with consistent revenue growth and robust profitability margins. The TTM data shows a gross profit margin of 75.67% and a net profit margin of 27.93%, indicating efficient cost management and strong profitability. The revenue growth rate of 3.77% in the TTM period, although lower than previous years, still reflects positive growth. Overall, the company maintains healthy EBIT and EBITDA margins, showcasing operational efficiency.
Balance Sheet
88
Very Positive
The balance sheet of Veeva Systems is solid, characterized by a low debt-to-equity ratio of 0.0128, indicating minimal leverage and financial risk. The return on equity (ROE) is 13.40% in the TTM period, reflecting effective use of equity to generate profits. The equity ratio stands at a strong 86.93%, highlighting the company's reliance on equity financing and a stable financial structure.
Cash Flow
82
Very Positive
Veeva Systems shows strong cash flow generation with a free cash flow to net income ratio of 98.77% in the TTM period, indicating efficient conversion of earnings into cash. The operating cash flow to net income ratio is 145.83%, demonstrating robust cash flow from operations. Free cash flow growth of 2.47% in the TTM period, while positive, suggests a slower growth trajectory compared to previous periods.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue2.75B2.36B2.16B1.85B1.47B
Gross Profit2.05B1.69B1.55B1.35B1.06B
EBITDA730.82M461.96M488.21M532.94M407.25M
Net Income714.14M525.71M487.71M427.39M380.00M
Balance Sheet
Total Assets7.34B5.91B4.80B3.82B3.05B
Cash, Cash Equivalents and Short-Term Investments5.15B4.03B3.10B2.38B1.66B
Total Debt75.78M55.77M60.98M54.59M63.12M
Total Liabilities1.51B1.27B1.09B904.83M779.75M
Stockholders Equity5.83B4.64B3.72B2.91B2.27B
Cash Flow
Free Cash Flow1.07B885.14M766.96M750.25M542.56M
Operating Cash Flow1.09B911.34M780.47M764.46M551.25M
Investing Cash Flow-700.14M-1.08B-1.01B-346.15M-333.63M
Financing Cash Flow26.11M-16.19M-19.38M-4.14M33.82M

Veeva Systems Technical Analysis

Technical Analysis Sentiment
Negative
Last Price241.33
Price Trends
50DMA
282.42
Negative
100DMA
281.58
Negative
200DMA
263.91
Negative
Market Momentum
MACD
-13.86
Positive
RSI
25.56
Positive
STOCH
14.05
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For VEEV, the sentiment is Negative. The current price of 241.33 is below the 20-day moving average (MA) of 268.75, below the 50-day MA of 282.42, and below the 200-day MA of 263.91, indicating a bearish trend. The MACD of -13.86 indicates Positive momentum. The RSI at 25.56 is Positive, neither overbought nor oversold. The STOCH value of 14.05 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for VEEV.

Veeva Systems Risk Analysis

Veeva Systems disclosed 43 risk factors in its most recent earnings report. Veeva Systems reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Veeva Systems Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$8.82B62.006.78%15.45%37.72%
74
Outperform
$36.54B16.5924.22%0.18%3.52%32.21%
72
Outperform
$9.62B40.7424.61%20.21%44.14%
67
Neutral
$5.78B53.474.25%17.23%
66
Neutral
$39.52B46.7213.72%15.96%27.91%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
49
Neutral
$13.16B-72.61%72.58%76.81%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
VEEV
Veeva Systems
241.33
9.67
4.17%
HQY
Healthequity
98.64
-2.20
-2.18%
DOCS
Doximity
51.53
-3.79
-6.85%
GEHC
GE Healthcare Technologies Inc
83.59
2.18
2.68%
BTSG
BrightSpring Health Services, Inc.
35.12
16.61
89.74%
TEM
Tempus AI, Inc. Class A
74.91
21.75
40.91%

Veeva Systems Corporate Events

Veeva Systems Inc. Earnings Call Highlights Growth and Challenges
Nov 22, 2025

Veeva Systems Inc. recently held its earnings call, presenting a balanced view of its performance. The company showcased robust revenue growth and innovation, particularly in AI and Crossix, while also addressing challenges in customer retention within the CRM segment and potential revenue risks from customer migrations.

Veeva Systems Reports Strong Q3 Earnings Growth
Nov 21, 2025

Veeva Systems Inc. is a leading provider of cloud-based solutions tailored for the global life sciences industry, offering software, data, and consulting services to enhance productivity and customer engagement. In its fiscal 2026 third quarter, Veeva Systems reported strong financial results with total revenues reaching $811.2 million, marking a 16% increase from the previous year. Subscription services, a major revenue driver, rose by 17% to $682.5 million. The company also highlighted significant advancements in its AI initiatives, aiming to transform productivity within the life sciences sector.

Executive/Board Changes
Veeva Systems Announces Chief Accounting Officer Resignation
Neutral
Nov 18, 2025

On November 17, 2025, Veeva Systems Inc. announced that Kristine Diamond, the Chief Accounting Officer, will resign from her position effective December 11, 2025. Following her departure, Brian Van Wagener, the Chief Financial Officer, will temporarily assume the role of principal accounting officer until a successor is appointed.

The most recent analyst rating on (VEEV) stock is a Buy with a $321.93 price target. To see the full list of analyst forecasts on Veeva Systems stock, see the VEEV Stock Forecast page.

Veeva Systems’ Earnings Call Highlights Strategic Wins
Sep 1, 2025

Veeva Systems Inc. recently held an earnings call that conveyed a generally positive sentiment, underscored by strong financial performance and strategic advancements. The company highlighted significant progress, particularly with the resolution of the IQVIA lawsuit and advancements in AI development. While challenges such as resistance to certain products and flat growth in one segment were noted, the overall outlook remains optimistic due to these positive developments and future potential.

Veeva Systems Reports Strong Q2 Earnings Growth
Aug 28, 2025

Veeva Systems Inc., a prominent provider of cloud-based solutions for the life sciences industry, has reported its fiscal 2026 second-quarter earnings, showcasing significant growth in revenue and profitability.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 22, 2025